Jonathan Hsu
7Patents
2h-index
22Co-inventors
43Inventor score
Filing activity: Nov 28, 2016 → Sep 22, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11965025B2 | Method of treating solid cancers with bispecific interleukin-anti-TCRß molecules | Chemistry; Metallurgy | 5 | Active |
| US11845797B2 | Anti-TCR antibody molecules and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US11248055B2 | Polypeptides inhibiting CD40L | Chemistry; Metallurgy | 0 | Active |
| US12406749B2 | Systems and methods for predicting repair outcomes in genetic engineering | Chemistry; Metallurgy | 0 | Active |
| US12358982B2 | Multifunctional molecules that bind to T cell related cancer cells and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12286477B2 | Anti-TCR antibody molecules and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12351632B2 | Anti-TCR antibody molecules and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.